{"name":"Prilenia","slug":"prilenia","ticker":"","exchange":"","domain":"prilenia.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFA3czdwNmR5WkQ5cHJ5eFkwNEZWYU5OVnBuVlpEcDdRMVF4bmRLbEJfU0NNTFdhczZVeXkyYmEzaHo4czFSNzFuV0ppZE9FdC1BMXpBb3c0RlB3VXV0YXJUOHhR?oc=5","date":"2026-01-19","type":"pipeline","source":"Labiotech.eu","summary":"10 promising biotechs racing toward a cure for ALS - Labiotech.eu","headline":"10 promising biotechs racing toward a cure for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQcHZBRW9jT0FnSHNjSi1BSGFIM1dXempPcldUWERHY0lxWVpTcFkyTjE2NnZ3X29nU0ExLWEzcFJ3VUpEUWxKSTVISnlKU296OF9lZXNUckc4X3BhVko3dDZUcWRGUlQ1WUtqLW9CVUhTakJ1X0NqNHBzMkx5MjdTTHBRX0FqMTdvcjJlVEdHZ2hkbjctMTB1eXpnSUQ1MVNQT0E?oc=5","date":"2026-01-05","type":"regulatory","source":"NeurologyLive","summary":"FDA Action Update, December 2025: Acceptance, Approval, and Clearance - NeurologyLive","headline":"FDA Action Update, December 2025: Acceptance, Approval, and Clearance","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbmpyV2tCTUZ1NHlET3ktejIwXzBCMXZaOXhRdy1KbVNEcGdWYVEzaHNiNElDWnNQTFVrY09yUmJuMkRydlZVOW9vSHFkQ3RBbUtXRFBrcE04UkhRQ3JSWGJNOFd4dlJIdFYyMXZobEpUenZYWWlReEE0bU1mVGp0bVItSVlsb0dXUGF6VVFvMDNNVnJsMXQ5Q1NhdE5ZVjVfLWRmcXpLRWNlWVlZcy0ydlZjQkwzdUQt?oc=5","date":"2025-10-31","type":"pipeline","source":"Business Wire","summary":"Circle Pharma Appoints Rob Lauzen as Chief Financial Officer - Business Wire","headline":"Circle Pharma Appoints Rob Lauzen as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOZmk0QllGTGJKMmtDaGFJTFNvWXFFVjM4Tzl0ZVg1NTNqTldCbGQxcjFZcER4MFJPNmVBMW1MdFdHb2dLd010NnpIYzBxdVZqMkc1RUJOS3o1UGJyaldmZzlSRkdVMWlsODFoMjUzWUpoeERuemtXYktyVkpvbU4zbFpOTVVBNW9vb2ctcEc4NDJEMHppWGxrWGkzQ0NMMFdZYk1sWjM2WC02XzM0cEE?oc=5","date":"2025-07-25","type":"regulatory","source":"HDBuzz","summary":"Pridopidine Hits a Roadblock: EMA Says No to Approval for Huntington’s Disease Treatment - HDBuzz","headline":"Pridopidine Hits a Roadblock: EMA Says No to Approval for Huntington’s Disease Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQVlhHbEpDV2xxVUt2QVptZy1BM1ZyaEdtSlk1cmZYSk56OHVwcUVKRmVyNDZBWlVDR25GRmV3TjRJbGtJZnBLUUdDQmhfcEdVY3o4RFhZWFNpZzFyZVVhTFZUX2ZsRXVta2poVXFNTTV4QVN5SU1zTktBVDFfa3BMQw?oc=5","date":"2025-04-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"Prilenia and Ferrer to commercialise pridopidine in Europe - Pharmaceutical Technology","headline":"Prilenia and Ferrer to commercialise pridopidine in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdFY2bm5sNU1VdEFUNkRieFk0OEZiaFVLM1FESzZrc2wzS2ZRRGlwVV9ENnNYZkRfTUtIUFNfczNjbDRvLXNLVF95N25xOUtxYzg2NGozODdQWDZQNE13UDI3Z2Z3NkVPYXF5MlFucVU0VFFMMV8tNjVtdjVCMmplY19kckJ6dzFTQVJUVHBqWS02MFVabWRBbkl4bUVwbS1CZFNxNHJiRlgwcUE?oc=5","date":"2025-04-29","type":"deal","source":"Globes - Israel Business News","summary":"Prilenia signs deal for former Teva ALS drug worth up to €500m - Globes - Israel Business News","headline":"Prilenia signs deal for former Teva ALS drug worth up to €500m - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPbEI4Wm9GWXF1aE5KczZ6bFhHdzBoOF84cWhfZW9qY2J4UjY0MHBwYmJpUTJ1Yy02LWQzR3k5clpWN2ZERi10V2J0NHZtQWlYSk5nQ2JKeVliSVBMTXBZeUItNXFBNXp4ZGJrdmdJQ0RwV1d6MW1ROElvUU9CaF9jUkdBNjVfdXQwa0k2ZW1fMlhRaVpQc1RCZ2RBYmM5eW4tbEVsR2NxSnJWQXlsaTFnVnlKcw?oc=5","date":"2025-04-28","type":"deal","source":"Fierce Biotech","summary":"Ferrer inks licensing deal worth up to €500M for Prilenia's ALS asset - Fierce Biotech","headline":"Ferrer inks licensing deal worth up to €500M for Prilenia's ALS asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB5bWllMXVYM19KRV8wX0lYeldDMkJlMUtSR1AyVExHV2hmTzAwYWVHN3VhQXF5LTBqRGNYaTB4d0dqVEJhNGtITHJzbzYxdnBCWnNZ?oc=5","date":"2025-04-28","type":"deal","source":"FirstWord Pharma","summary":"Ferrer nabs European rights to Prilenia's Huntington's asset in €500M deal - FirstWord Pharma","headline":"Ferrer nabs European rights to Prilenia's Huntington's asset in €500M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNnVTOGdSN2xOZVd1cV9sejJQNnpUdTB5U2JkbnpGNHZIQU1aQTRBUzZTazJZRWpEY2xfZkFSZGhRM3NqLVZ0NVZoNXUxdFpfaVhDOW1wTzkzbUpoUkY1d1J6M3BBUUxsc2FLWWdDWHhBRGdFNjN0QVVEbElKUTRFOURxUl9mLVc1RWpRcHl2MVlsbmlVSUpxR0ZRNHhNWFZWQnNUWF92YU40RjdGYjNjV1p4OEpJY1hKVUJ2WDRTanRUQQ?oc=5","date":"2025-04-28","type":"deal","source":"Contract Pharma","summary":"Prilenia, Ferrer Partner to Commercialize & Further Develop Pridopidine in Europe - Contract Pharma","headline":"Prilenia, Ferrer Partner to Commercialize & Further Develop Pridopidine in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQYlAzaGI1eWxzcHE2dVY4enp1TU5fQUFuLUtRN0hWRGtvLUNlVTNBNFZzdVA2VDM3azNSZk95eEd1X2cxMWFwRkVEUkgtUnQwMzVOc2Q1QjNGc1l2ZVZOQkZqWVZ5cE1jQk5tRmpaQXFpWUR1Ny1hUnJpSG1yZEdKN1czb09YTDUxSFZaZ245MUFyY19Nc0pjdWxMVWJQS3M0WUpWM2hOYjhsMU5NOEFrUnJGbG1aUW5mQzFjN0VycXBBaXFyUF9WdGN0a0ZGOVNNX1pBbi1SNGdydlFjYlJjUmdQSDlfRDlTaWo2LUpVSXk2MC1iRVFmTEd2MWdBdzI4WndSTHQ5NW9DNWloZ2x5Wlg5V041TzFiWVpEb080dTNVc0NoeGE0ZkhHS2RuZw?oc=5","date":"2025-04-28","type":"deal","source":"BioSpace","summary":"Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets - BioSpace","headline":"Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPbzBaSTdRQXNuWkNoX29uY00wTzBQZnVlaDY5a1BuSVJ4ekNuenZqeFNIc3oyYnJaeEtKTW5TaHU4Ry1wYnJ0Qks3c2dicUFrSXF2QzZYejMzRGxtMzMweURxSGJiY3Q3azR1QzNDc1VkNENNMW5WZm9jZmtOTWlaSVhDcWEzWmJjUGMzcg?oc=5","date":"2024-03-13","type":"pipeline","source":"pharmaphorum","summary":"Prilenia eyes 2025 launch for Huntington’s drug pridopidine - pharmaphorum","headline":"Prilenia eyes 2025 launch for Huntington’s drug pridopidine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQU3Z0WXdMSGJBV3JjSHMwaTFqMFZsSUFUMllUOFRxd29hb1d6eklnZUlqRnBzR2duaWxhbDN1Z0dTVGRtVFp0SDJGTzF4NGIzakRXakJJWjJyZE1Ld3A2VHRqN19LOFFxaE1hNUdSbE16Y09UeWQ1TFN0UzR1NHBWdHZTYUY5OWxvajNuQVdjZ2FXUi10NVE?oc=5","date":"2023-10-06","type":"pipeline","source":"BioPharma Dive","summary":"NIH funds research for three experimental ALS drugs - BioPharma Dive","headline":"NIH funds research for three experimental ALS drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}